132 research outputs found
Toxicological studies of citreoviridin that is a mycotoxin contaminating rice and grains
ã·ãã¬ãªããªãžã³ïŒCTVDïŒã¯ãPenicillium citreonigrumãAspergillus terreusãEupenicillium ochrosalmoneumãªã©ãäºæ¬¡ä»£è¬ç£ç©ãšããŠç£çããã«ãæ¯ã§ãããCTVDãç£çããP. citreonigrumãªã©ã¯ç©é¡ã®ãã¡äž»ã«ã³ã¡ãæ±æãããããã³ã¡ãäž»é£ãšããã¢ãžã¢ãåç±³ãªã©ã®åœã
ã§CTVDã®æ±æã¯åé¡ãšãªããCTVDã«æ±æãããã³ã¡ãé»è²ããªãããšãããCTVDã¯é»å€ç±³æ¯ã®äžã€ãšããŠãç¥ãããŠãããæ¥æ¬åœå
ã§éå»ã«èŒžå
¥ç±³ã§ã®æ±æäºäŸãå ±åãããŠãããè¿å¹Žã«ãããŠããã¿ã€ããã©ãžã«ãªã©ç±åž¯æ§æ°åã®å°åã§CTVDç£çèœãæããP. citreonigrumã®ååšãå ±åãããŠããããCTVDã®æ¯æ§ã«ã€ããŠã¯ã1940幎ã«P. citreonigrumã«æ±æãããã³ã¡ã®ç²æœåºç©ãè
¹è
å
æäžïŒIPïŒãç®äžæäžïŒSCïŒåã¯çµå£æäžïŒPOïŒã«ããåºä¹³é¡ãèæ€åç©ã«æäžããå Žåã«ãåè¢ã®é²è¡æ§éº»çºãååãçæ£ã挞次çåŒåžé害ãªã©ãåŒãèµ·ããããšãããã€ãã®æ¯æ§åŠçç 究ããæãããšãªã£ãããã®åå ã«ãæ¯ãšããŠCTVDãåå®ããã粟補åãçšããåç©å®éšã«ãããŠãç¥çµçç¶ã®é²è¡æéã¯æ¯çŽ æœåºç©ã®çšéãå€ããªãã»ã©çããªãããšãå ±åãããŠãããããŠã¹ã«å¯ŸããCTVDã®LD50ã¯3.6-11.8 mg/kgïŒç®äžæäžïŒã7.5 mg/kgïŒè
¹è
å
æäžïŒãšãããŠãããããã§èµ·ããå¥åº·è¢«å®³ãšããŠã¯ãè¡å¿èæ°ãKeshanç
ãšã®é¢é£ãææãããŠããã2006幎ã«ãã©ãžã«ã§çºçããè¡å¿èæ°ã®ã¢ãŠããã¬ã€ã¯ã§ã¯ãåœè©²å°åã®ã³ã¡ããCTVDãç£çããP. citreonigrumãæ€åºãããŠãããåæ¯çŽ ãåå ç©è³ªãšããŠçãããŠããããæ¯æ§åŠç 究ã«ãããŠã¯ããã·ã³ãããã£ã¯ã¹ãäœå
åæ
ã®æ
å ±ãæ¬ ãããªãã ãCTVDã®æ¯æ§å®éšãçãã«è¡ãããŠãã1940幎代ãã1980幎代ã«ã¯åŸ®éåæãå¯èœãªåææ©åšçããªããæ床ã®äœãèå±€ã¯ãããã°ã©ãã£ãŒã«ããèå
åæã§ã®çµæã«çãŸã£ãŠãããããã§ãæ¬ç 究ã§ã¯CTVDã®ããã·ã³ãããã£ã¯ã¹ãæããã«ããç®çã§ã解ååŠçãççåŠçã«ãããšé¡äŒŒããŠãããã¿ãçšããCTVDã®æäžå®éšã«ããæ€èšããããŸãããããšã®æ¯èŒãè¡ããããããè
žç®¡çŽ°èã¢ãã«ã§ããCaco-2现èãçšããééå®éšåã³ä»£è¬é
µçŽ ãå«ãèèS9ç»åãçšãã代è¬å®éšãin vitroã§è¡ããããã«ãããCTVDã®ãã€ãªã¢ãã€ã©ããªãã£ãæšæž¬ãããæ¬ç 究ã®æŠèŠã¯æ¬¡ã®ãšããã§ãããâ
ãã¿ã«ãããCTVDã®ããã·ã³ãããã£ã¯ã¹ãçŽ10 kgã®ãã¿ã«CTVD 0.1 mg/kg bwãéèæäžåã³çµå£æäžãããç¶æçã«è¡æ¶²ãæ¡åããåé¢ããè¡æŒ¿äžã®CTVDæ¿åºŠãLC-MS/MSã§åæãããåæçµæãã解æãœãã(WinNonlin)ãçšããŠããã·ã³ãããã£ã¯ã¹ãã©ã¡ãŒã¿(TKãã©ã¡ãŒã¿)ãç®åºãã次ã®çµæãåŸããïŒïŒïŒéèæäžåŸã®CTVDã®è¡æŒ¿äžæ¿åºŠã¯ãæäžåŸæ¥æ¿ã«æžå°ããæçµæ¡è¡æç¹ã§ãã48æéåŸãŸã§ç·©ããã«æžå°ããã48æéåŸã§ãè¡æŒ¿äžããCTVDãæ€åºããããïŒïŒïŒéèæäžæã®TKãã©ã¡ãŒã¿ã¯ãå°ããªé床å®æ°ïŒKelïŒïŒ0.5 ± 0.1 Ã10-1 h-1ïŒã瀺ããåæžæïŒT1/2ïŒåã³ååžå®¹ç©ïŒVdïŒã¯ãããã16.2 ± 4.3 hã1.5 ± 0.2 Lã§ãã£ããïŒïŒïŒçµå£æäžåŸã®CTVDã®è¡æŒ¿äžæ¿åºŠã¯ãæäžåŸç·©ããã«äžæãã15.0 ± 6.0 hïŒTmaxïŒã§ããŒã¯ïŒCmaxïŒ38.2 ±6.7 ng/mLïŒãè¿ããã®ã¡ã48æéåŸãŸã§ç·©ããã«æžå°ãããïŒïŒïŒçµå£æäžæã®TKãã©ã¡ãŒã¿ã¯ãéèæäžãšåæ§ã«Kelãå°ããïŒ0.4±0.2 Ã10-1 h-1ïŒãæ¯èŒçé·ãT1/2ïŒ21.4 ± 12.7 hïŒãšå€§ããªVdïŒ1.7 ± 0.3 LïŒã瀺ãããïŒïŒïŒCTVDã®ãã¿ã«ããããã€ãªã¢ãã€ã©ããªãã£ã¯ãæäžåŸ48æéãŸã§ã§79.3 %ãšæ¯èŒçé«ããç¡éæéãŸã§å€æ¿ããå Žåã«ã¯116.4%ã瀺ããããããã®çµæãããCTVDã¯ãã¿ã«ãããŠé«ããã€ãªã¢ãã€ã©ããªãã£ãæã€ããšã瀺åãããããŸããCTVDã¯äœå
ããã®æ¶å€±ãé
ããçµç¹ç§»è¡æ§ãé«ããšèããããæ¯èŒçé·ãäœå
ã«æ®çããããšã瀺åããããâ
¡ ããè
žç®¡å¹é€çŽ°èCaco-2现èãçšããCTVDã®ééä¿æ°ãããã«ãããCTVDã®ãã€ãªã¢ãã€ã©ããªãã£ãæšå®ãããããããè
žç®¡çŽ°èã¢ãã«ã§ããCaco-2现èãçšããééå®éšãå®æœãããCorningTM BioCoatTM Intestinal Epithelium Differentiation Environment Kitãçšããåå±€ã«å¹é€ããCaco-2现èã®ç²èé¢åŽã«CTVDïŒ3 µMåã³10 µMïŒãæŽé²ãã37âã§ã€ã³ãã¥ããŒãããã2æéåŸã®ç²èé¢åŽåã³åºåºèé¢åŽã®å¹å°ãæ¡åããå¹å°äžã®CTVDæ¿åºŠãLC-MS/MSãçšããŠæž¬å®ããŠãçµäžç®é»æ°æµæå€ïŒTEERïŒåã³ééä¿æ°ïŒPappïŒãæ±ããããã®çµæãïŒïŒïŒãããã®CTVDæ¿åºŠã«ãããŠãTEERã«å€åã¯èªããããªãã£ããïŒïŒïŒåCTVDæ¿åºŠã«ãããPappã¯ããããã52.2 ± 28.3ã42.6 ± 17.7 ïŒÃ10-6 cm/sïŒã§ãããæ¯èŒçé«ãééä¿æ°ã瀺ãããããããããCTVDã¯ãã¿ãšåæ§ã«ããã«ãããŠãäœå
ã«åžåãããããããšã瀺åããããé«ãééä¿æ°ã¯ãCTVDã®è溶æ§ã®é«ããåæ ããçµæãšèãããããâ
¢ ãã¿åã³ããèèS9ç»åãçšããCTVDã®ä»£è¬ãšãã®ä»£è¬ç©ããã¿ãçšããCTVDã®in vivoå®éšã«ãããŠãè¡æŒ¿äžCTVDæ¿åºŠãæ¯èŒçç·©ããã«æžå°ãã48æéåŸã«ãããŠãè¡æŒ¿äžã«æ®çããŠããããšããããã¿ã«ãããŠã¯ä»£è¬ãæ¯èŒçé
ãå¯èœæ§ã瀺åãããããã®ãã代è¬é
µçŽ ãå«ããã¿åã³ããã®èèS9ç»åãçšãã代è¬å®éšã«ããCTVDãžã®ä»£è¬èœãæ¯èŒãããå§ãã«ã°ã«ã³ãŒã¹âïŒâãªã³é
žïŒG-6-PïŒåã³NADPãå«ã溶液äžã«èèS9ç»åïŒ0.5 mg/mLïŒåã³CTVDïŒ1.5 µg/mLïŒãå ãã37âã§ã€ã³ãã¥ããŒããããã€ã³ãã¥ããŒãåŸ30åã1æéåã³4æéåŸã®æº¶æ¶²ãæ¡åããQ-TOFã§åæããããã®çµæãïŒïŒïŒCTVDã®ä»£è¬ç©ã¯äž»ã«æ°Žé
žå-ã¡ãã«åäœãäžé£œååäœåã³ãžããããã·åäœã§ããããšãæšæž¬ããããïŒïŒïŒãããã®ä»£è¬ç©ãããèèS9ç»åãçšããã»ãããã¿èèS9ç»åãçšãããããææã«å€ãç£çããããïŒïŒïŒCTVDæ¿åºŠããã¿èèS9ç»åãçšãããããããèèS9ç»åãçšããã»ããææã«äœäžãããããããããCTVDã¯ããã¿ã«ãããŠS9ã«ãã代è¬ãé
ãããšã瀺åãããããã«ãããŠã¯ãã¿ãããCTVDã代è¬ããããããšãèããããããS9ç»åãçšãã代è¬å®éšã«ãããŠãã°ã«ã¯ãã³é
žæ±åäœãç£çãããªãã£ãããšããããŠãªãžã³äºãªã³é
žã°ã«ã¯ãã³é
žåã³ã¢ã©ã¡ãã·ã³ã®ååšäžã§CTVDãšS9ç»åãã€ã³ãã¥ããŒãããŠãCTVDã®ã°ã«ã¯ãã³é
žæ±åäœã®ç£çã調ã¹ãããã®çµæãïŒïŒïŒãããã®S9ç»åãçšããå Žåã§ããã€ã³ãã¥ããŒãåŸ30åãŸã§ã«CTVDã®ã°ã«ã¯ãã³é
žæ±åäœã¯ç£çãããªãã£ããïŒïŒïŒã€ã³ãã¥ããŒãåŸ4æéã§ãã¿èèS9ç»åãçšããã»ããããèèS9ãçšãããããææã«ã°ã«ã¯ãã³é
žæ±åäœãç£çããããããããããCTVDã®ã°ã«ã¯ãã³é
žæ±åäœã«ã€ããŠã¯ãã¿ã®ã»ãããããããç£çãããããããšã瀺åãããããæ¬ç 究ã§ã¯ãin vivoã«ããããã¿ã§ã®CTVDã®ããã·ã³ãããã£ã¯ã¹ã®çµæãããCTVDãäœå
ã«åžåããããããé·ãåæžæãšå€§ããååžå®¹ç©ãæã€ããšã瀺ãããããããã®ããšããæ¯èŒçé·ãäœå
ã«æ®çããããšãæããã«ããããŸããCTVDã®ãã€ãªã¢ãã€ã©ããªãã£ã¯ãã¿ã«ãããŠé«ãã ãã§ãªããããã«ãããŠãé«ãå¯èœæ§ãin vitroã§æããã«ãããäžæ¹ã§ãCTVDã®ä»£è¬ã«ã€ããŠã¯ãããã§ã¯ãã¿ãããæ©ãããã°ã«ã¯ãã³é
žæ±åäœåœ¢æèœã¯ãã¿ã®ã»ããåªããŠããããšãin vitroã®èŠ³ç¹ããæããã«ãããCitreoviridin (CTVD) is a mycotoxin that is a secondary metabolite produced by Penicillium citreonigrum, Aspergillus terreus and Eupenicillium ochrosalmoneum. Because P. citreonigrum capable of producing CTVD contaminates mainly rice, contamination with CTVD can be problem in countries of Asia and South America, where rice is a staple food. CTVD is a yellow rice toxin, and a case of its contamination in an imported rice sample was previously reported in Japan. Recently, the occurrence of P. citreonigrum capable of producing CTVD has been reported in areas with a tropical climate, such as Thailand and Brazil.Regarding toxicity of CTVD, in the 1940s, several toxicological studies revealed that symptoms such as progressive paralysis, vomiting, convulsions and temporary respiratory disturbance developed when a crude extract from contaminated rice was administered to mammals and other vertebrates via intraperitoneal (IP), subcutaneous (SC) and oral (PO) routes. Furthermore, it was found that isolated CTVD causes the same symptoms as experiments using moldy rice. Neurological symptoms progressed faster at higher doses of extracted toxin, and the median lethal dose (LD50) of CTVD for mice has been reported be 3.6 to 11.8 mg/kg (SC) and 7.5 mg/kg (IP). As a human adverse effects, CTVD has been considered to be related to Shoshin-kakke (acute cardiac beriberi) and Keshan disease which adversely affects the heart. In 2006, an outbreak of Shoshin-kakke occurred in Brazil, and the presence of rice contaminated with P. citreonigrum capable of producing CTVD was reported in the outbreak area.An understanding of toxicokinetics is essential when performing a toxicological study. However, from the 1940s to the 1980s, when toxicological studies of CTVD were performed actively, no high-resolution analytical methods had yet been developed, and the toxicokinetics of CTVD were determined based solely on the results of a fluorescence analysis using thin layer chromatography.The present study was conducted with the following three experiments: (1) the toxicokinetics of CTVD were investigated by administering CTVD to swine, which are similar to humans both anatomically and physiologically; (2) the permeability of CTVD was investigated using Caco-2 cells, which are a model of human intestinal cells; and (3) a CTVD metabolic study was conducted using the swine or human hepatic S9 fraction containing metabolic enzymes. The bioavailability of CTVD to humans was estimated, while in addition the toxicokinetics of CTVD in vitro to humans was compared with that to swine on studies (2) and (3). I. Toxicokinetics of CTVD in swineCTVD (0.1 mg/kg body weight) was administered to swine (weighing about 10 kg) intravenously (IV) and PO. The CTVD concentration of plasma samples was determined via liquid chromatography with tandem mass spectrometry (LC-MS/MS). The toxicokinetics parameters (TK) were analyzed, and the following results were obtained: (1) the CTVD concentration in plasma decreased quickly shortly after IV administration and then continued to decrease moderately until 48 h (final sampling point); however, some amount of CTVD remained in plasma even at 48 h after administration. (2) The rate constant (Kel) after IV administration was 0.5 ± 0.1 à 10 -1 h-1. The half-life (T1/2) and volume of distribution (Vd) were 16.2 ± 4.3 h and 1.5 ± 0.2 L, respectively. (3) The CTVD concentration in plasma in PO gently increased after administration and reached the maximum concentration (Cmax: 38.2 ± 6.7 ug/mL) at 15.0 ± 6.0 h (Tmax), after which it moderately decreased until 48 h. (4) The Kel after PO administration was small (0.4 ± 0.2 à 10-1 h-1, similar to that in IV). The T1/2 and Vd were 21.4 ± 12.7 h and 1.7 ± 0.3 L, respectively. (5) The bioavailability of CTVD was 79.3% from 0 to 48 h and 116.4% on extrapolating from 48 h to infinity. These results suggested that CTVD had a high bioavailability in swine. In addition, CTVD was eliminated slowly from the body and was easily distributed to tissues. These findings suggested that CTVD remained in the body for a relatively long time after administration.II. Permeability of CTVD for Caco-2 cells, a human intestinal cell modelBecause CTVD had a relatively high bioavailability in swine, a permeability study was performed using Caco-2 cells, which are a human intestinal cell model. CTVD (3 ÎŒM and 10 ÎŒM) was treated to the apical side (AP) of Caco-2 cells cultured in a monolayer using a CorningTM BioCoatTM Intestinal Epithelium Differentiation Environment Kit (Corning, NY, USA) and then incubated at 37 °C. After 2 h, the culture medium was sampled from the AP and basolateral side (BL). The CTVD concentration was determined using LC-MS/MS, and then the transepithelial electrical resistance (TEER) and permeability coefficient (PaPP) were estimated. The results of this study were as follows: (1) The TEER was unchanged at each concentration of CTVD. (2) The PaPP values at each CTVD concentration of 3 ÎŒM and 10 ÎŒM were 52.2 ±28.3 and 42.6 ± 17.7 (Ã10-6 cm/s), respectively, indicating a relatively high permeability. These findings suggested that CTVD could be easily absorbed by the human intestine, similar to swine, which reflected a high lipid solubility of CTVD.III. CTVD metabolism and its metabolites as assessed using swine and human hepatic S9 fractionsOur in vivo study showed that the plasma CTVD concentration decreased gently, and CTVD was still detected even at 48 h after administration. Given these results, the CTVD metabolism was next investigated using swine and human hepatic S9 fractions containing metabolic enzymes. CTVD was incubated at 37 °C with hepatic S9 fraction in solution containing glucose-6-phosphate (G6P) and NADP. The solution was sampled at 30 min, 1 and 4 h after incubation, and then the concentrations of CTVD and its metabolites were determined using a quadrupole time-of-flight mass spectrometer (Q-TOF). The findings were as follows: (1) The CTVD metabolites were estimated to be hydroxylation-methylation, desaturation and dihydoroxylation derivatives. (2) Each metabolite was produced in greater quantities using the human hepatic S9 fraction than the swine hepatic S9 fraction. (3) The CTVD concentration was significantly lower with the human hepatic S9 fraction than with the swine hepatic S9 fraction. These results suggested that CTVD was slowly metabolized in swine, which may have been the cause of the slow elimination rate noted in the swine in the in vivo study. In addition, humans seemed to more readily metabolize CTVD than swine.Because CTVD glucuronide was unable to be detected in the metabolic study using S9 fractions in the presence of G6P and NADP, CTVD was incubated with an S9 fraction in the presence of UDP-glucuronic acid and alamethicin to examine CTVD glucuronidation ability. The following results were obtained: (1) CTVD glucuronide had not been produced by 30 min after incubation, regardless of the fraction used. (2) The levels of CTVD glucuronide at 4 h after incubation were significantly greater with the swine hepatic S9 fraction than with the human hepatic S9 fraction. These findings suggested that CTVD glucuronide was more readily produced in swine than in humans.The present studies showed that CTVD is easily absorbed by the body and has a long T1/2 and large Vd, indicating that CTVD persists for a relatively long time in the body. In addition, the bioavailability of CTVD appeared to be high in both humans and swine. Regarding CTVD metabolism, humans were able to metabolize CTVD earlier than swine according to in vitro findings, while the glucuronidation ability for CTVD was better in swine than in human from an in vitro perspective.å士(åŠè¡)麻åžå€§
Instability of Population III Black Hole Accretion Disks
We investigate the stability of black hole accretion disks in a primordial
environment (POP III disks for short), by solving the vertical structure of
optically thick disks, including convective energy transport, and by employing
a one-zone model for optically thin isothermal disks. Because of the absence of
metals in POP III disks, we find significant differences in stability
associated with ionization between POP III disks and the disks of solar
metallicity. An unstable branch in S-shaped equilibrium curves on the
Mdot-Sigma (mass accretion rate - surface density) plane extends to a larger
surface density compared with the case of disks of solar metallicity. The
resulting equilibrium loci indicate that quasi-periodic oscillations in
luminosity can also be driven in POP III disks, and their maximal luminosity is
typically by an order of magnitude larger than that of the disks of solar
metallicity. Such a strong outburst of POP III disks can be observed by future
huge telescopes, in case that the mass is supplied onto the disks at the Bondi
accretion rates in typical virialized small dark halos.Comment: 7 pages, 4 figures, accepted for publication in PAS
Association Between Eosinophilia and Late-onset Circulatory Collapse in Preterm Infants: A case-Control Study
Late-onset circulatory collapse (LCC) in preterm infants is presumably caused by relative adrenal insufficiency. Because eosinophilia is known to be associated with adrenal insufficiency, we attempted to clarify the relation-ship between eosinophilia and LCC in preterm infants. We divided the cases of the infants (born at < 28 weeksâ gestation) admitted to our neonatal intensive care unit in 2008-2010 into 2 groups: those diagnosed with LCC that received glucocorticoids (LCC group), and those who did not receive glucocorticoids (control group). We compared eosinophil counts between the 2 groups and between before and after glucocorticoid treatment in the LCC group. A total of 28 infants were examined: LCC group (n = 12); control group (n = 16). The peak eosin-ophil counts of the LCC group were significantly higher than those of the control group (median: 1.392 Ã 109/L vs. 1.033 Ã 109/L, respectively; p = 0.02). Additionally, in the LCC group, the eosinophil counts declined significantly after glucocorticoid treatment (0.877 Ã 109/L vs. 0.271 Ã 109/L, p = 0.003). Eosinophil counts in the LCC group were significantly higher than in the control group and decreased rapidly after gluco-corticoid treatment. These results indicate that eosinophilia may be a factor associated with LCC caused by adrenal insufficiency
Gig workers, social protection and labour market inequality: lessons from Malaysia
The rise of the Gig Economy has created new concerns about inequality in rapidly digitising Asian economies. Whilst the emergence of the âon-demand economyâ creates new opportunities for the youths and low-income groups, this has also created new policy challenges. As many use unofficial digital platforms and/or operate as unregistered self-run businesses, they remain outside the social protection system, leaving them especially vulnerable during times of crisis. This study therefore aims to provide new insights into this issue - social protection for gig workers â drawing upon the Malaysian experience. Using primary data collected through semi-structured interviews, we examine the working conditions of e-hailing drivers and online food delivery riders, two of the largest mainstream on-demand appbased gig workersâ groups in the country. The collected data were examined based on thematic analysis employing 15 subtopics and 3 main themes: (i) performance-based short-term decent work; (ii) platform and customer-centricity operations, and (iii) ecosystem for gig worker sustainability. From the perspective of gig workers, the study narrates their actual working conditions and perceived inequalities. Based on the findings, we conclude by critically reflecting on the potential for developing a worker-centred policy for social protection in the Gig Economy in Malaysia and elsewhere in Asia
Is the number of covered intercostal arteries a predictor of postoperative spinal cord ischemia after thoracic endovascular aortic repair?
Objective: The purpose of this study was to investigate the impact of the number of covered intercostal arteries (ICAs) on postoperative spinal cord ischemia (SCI) after Thoracic endovascular aortic repair (TEVAR).Methods: A retrospective review of a collected database was performed for all patients who underwent TEVAR at the Sapporo Medical University between January 2006 and February 2016. The pre- and post-operative thin slice contrast-enhanced computed tomography was performed, and ICAs were evaluated. Preoperative demographics, procedure-related variables, and clinical details related to SCI were examined. Logistic regression analysis was performed to identify risk factors for the development of SCI.Results: Of the 263 patients who underwent TEVAR during the study period, 11 patients (4.1%) developed SCI. The number of patent preoperative ICAs was 10.1 ± 4.4. There was no significant difference in the number of patent ICAs between the SCI and No SCI groups. On the other hand, the number of postoperative covered ICAs was 4.8 ± 3.3. The number of covered ICAs was higher in the SCI than No SCI group (8.3 ± 2.9 vs 4.7 ± 3.2, p = 0.001). The cut-off value was set at 6 ICAs by ROC curve analysis. Multivariate analysis demonstrated that in TEVAR, the covering of 6 or more ICAs by stent grafts became a significant risk factor for SCI (odds ratio, 10.9; p = 0.029).Conclusions: The number of covered ICAs becomes a predictor of postoperative SCI after TEVAR. The patient with 6 or more ICAs covered by stent grafts is deemed to require a more careful perioperative management
Labour Unionâs challenges for improving for gig work conditions on food delivery in Japan: a lesson for Malaysia
The development of technology and the flexibility to work in nontraditional ways has led to the emergence of task-based gig workers and this trend has been spreading across Japan. However, the ambiguity of the legal position on app-based on-demand gig workers has led to inequalities in labour relations. This study examines the labour union actions against the employers and related bodies of the online food delivery platform Uber Eats Union to determine the current status and potential for bargaining. The union has requested collective bargaining on the Uber side, but all requests have been rejected. The admissibility of the unionâs actions to improve industrial relations depended on two points: the application of the worker character in the law to the delivery workers and the demand for support from other institutions. In terms of the law, the recognition of the worker status of delivery workers is a significant step towards collective bargaining with firms. The active work of the Uber Eats Union could lead to the formation of new labour unions on other platforms and the empowerment of platform workers. Based on Japanâs experience, this paper also draws some lessons for Malaysiaâs gig economy
- âŠ